ArticleJournal of obesity2026
Effect of Normal Level Endocrine Hormones and Hypothalamic Neuropeptides on Obesity in Women of Childbearing Age.
Article in Journal of obesity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effect of Normal Level Endocrine Hormones and Hypothalamic Neuropeptides on Obesity in Women of Childbearing Age.Journal of obesity · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
aimsTo explore the association of endocrine hormones and hypothalamic neuropeptides fluctuations within normal level with obesity in women of childbearing age. MATERIALS AND
methodsLaboratory data of women in childbearing age with normal levels of endocrine hormones and hypothalamic neuropeptides in Heilongjiang Provincial Hospital between March 2022 and October 2022 were retrospectively collected. Included subjects were divided into obese group and normal weight group according to body mass index.
results80 subjects were included in final analysis, including 37 in the obese group and 43 in the normal weight group. Within the normal range, the levels of cortisol, adrenocorticotropic hormone, free triiodothyronine, free thyroxine, follicle-stimulating hormone, neuropeptide Y, and orexin were positively correlated with body mass index, while the levels of estradiol and oxytocin were negatively correlated with body mass index; the levels of adrenocorticotropic hormone, thyroid-stimulating hormone, neuropeptide Y, and orexin were positively correlated with triglycerides, while proopiomelanocortin level was negatively correlated with triglycerides; neuropeptide Y level was positively correlated with total cholesterol, and cortisol level was negatively correlated with high-density lipoprotein cholesterol. Elevated levels of neuropeptide Y and orexin were independent risk factors for obesity (OR = 1.123, 95% CI = 1.023-1.232, p = 0.015; OR = 4.004, 95% CI = 1.174-13.656, p = 0.027), while increase in oxytocin level was an independent protective factor (OR = 0.833; 95% CI = 0.697-0.995; p = 0.044).
conclusionsAmong women of childbearing age, fluctuations in multiple endocrine hormones and hypothalamic neuropeptides within the normal range play a crucial role in regulating body weight and plasma lipids. Specifically, relatively higher levels of neuropeptide Y and orexin increase obesity risk, while elevated oxytocin levels reduce this risk. These identified biomarkers may offer candidates for subsequent mechanistic research and clinical interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.